Hrvatska - hrvatski - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

krka - farma d.o.o., zagreb, hrvatska - vitamin a, d3, e, c, k3, b1, b2, b6, b12, nikotinamid, kalcijev pantotenat i selen - prašak za peroralnu otopinu - peradi, svinja, goveda, ovaca, koza, konja i kunića

Hrvatska - hrvatski - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

genera d.d., svetonedeljska 2, kalinovica, 10436 rakov potok, hrvatska - tiamin klorid (vit. b1); riboflavin natrij-fosfat (vit. b2); piridoksin klorid (vit. b6); nikotinamid; askorbinska kiselina (vit. c) - injekcijska otopina - konja, goveda, ovaca, koza svinja, pasa i mačaka

Hrvatska - hrvatski - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

genera d.d., kalinovica, rakov potok, hrvatska - retinol (vit.a); kolekalciferol (vit.d3); a-tokoferil acetat (vit.e) - injekcijska otopina - pasa i mačaka

Hrvatska - hrvatski - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

genera d.d., kalinovica, rakov potok, hrvatska - askorbinska kiselina - injekcijska otopina - konja, goveda, svinja, ovaca, koza, pasa i mačaka

Europska Unija - hrvatski - EMA (European Medicines Agency)

alnylam netherlands b.v. - vutrisiran sodium - amyloid neuropathies, familial - ostali lijekovi protiv živčanog sustava - treatment of hereditary transthyretin-mediated amyloidosis (hattr amyloidosis) in adult patients with stage 1 or stage 2 polyneuropathy.

Europska Unija - hrvatski - EMA (European Medicines Agency)

alnylam netherlands b.v. - patisiran natrija - Амилоидоз, obiteljska - ostali lijekovi protiv živčanog sustava - onpattro indiciran za liječenje nasljednih транстиретина-посредничанного амилоидоза (hattr амилоидоз) u odraslih bolesnika s fazi 1 ili 2 fazi полинейропатии.

Europska Unija - hrvatski - EMA (European Medicines Agency)

viatris limited - klopidogrel besilat - peripheral vascular diseases; stroke; myocardial infarction - antitrombotska sredstva - secondary prevention of atherothrombotic events clopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. adult patients suffering from acute coronary syndrome. non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). porastom segmenta st akutni infarkt miokarda, u kombinaciji s ask u liječenju pacijenata koji imaju pravo na thrombolytic terapije. in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is) clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. prevention of atherothrombotic and thromboembolic events in atrial fibrillation:in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. za više informacija, molimo pogledajte odjeljak 5.

Europska Unija - hrvatski - EMA (European Medicines Agency)

taw pharma (ireland) limited - klopidogrel hidroklorid - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - antitrombotska sredstva - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:,    - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). ,     - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2  score ≥4) or minor is (nihss  ≤3) within 24 hours of either the tia or is event.  , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.

Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

delta pharma d.o.o. sarajevo - enoksaparina - rastvor za injekciju u napunjenoj šprici - 100 mg/1 ml - jedna napunjena injekciona šprica sadrži 2000 i.j. antixa aktivnosti enoksaparinnatrijuma (što odgovara 20 mg) u 0,2 ml vode za injekcije (100 mg/ml)

Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

delta pharma d.o.o. sarajevo - enoksaparina - rastvor za injekciju u napunjenoj šprici - 100 mg/1 ml - jedna napunjena injekciona šprica sadrži 2000 i.j. antixa aktivnosti enoksaparinnatrijuma (što odgovara 20 mg) u 0,2 ml vode za injekcije (100 mg/ml)